| mRNA |
PLX4720 |
CTRPv2 |
pan-cancer |
AAC |
0.38 |
6e-22 |
| mRNA |
PLX4720 |
CCLE |
pan-cancer |
AAC |
0.49 |
2e-17 |
| mRNA |
salermide:PLX-4032 (12:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.29 |
3e-12 |
| mRNA |
GDC-0879 |
CTRPv2 |
pan-cancer |
AAC |
0.26 |
9e-12 |
| mRNA |
dabrafenib |
CTRPv2 |
pan-cancer |
AAC |
0.31 |
7e-10 |
| mRNA |
PD-0325901 |
CCLE |
pan-cancer |
AAC |
0.33 |
1e-08 |
| mRNA |
AZD6244 |
CCLE |
pan-cancer |
AAC |
0.31 |
1e-07 |
| mRNA |
selumetinib:piperlongumine (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
4e-06 |
| mRNA |
PD318088 |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
2e-05 |
| mRNA |
erlotinib:PLX-4032 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
8e-05 |